Evidence map›Paper›PMID 17256858›Full record

ArticleJournal of the American Chemical Society2007

Fluorescent pyrimidine ribonucleotide: synthesis, enzymatic incorporation, and utilization.

Seergazhi G Srivatsan, Yitzhak Tor

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 161 citations in OpenAlex.

  1. Isothiazologuanosine (Angewandte Chemie (International ed. in English) · 2026
    Article
  2. Article
  3. Article
  4. Isomorphic Fluorescent Nucleosides.Accounts of chemical research · 2024
    Article
  5. Article
  6. Total RNA Synthesis and its Covalent Labeling Innovation.Topics in current chemistry (Cham) · 2022
    Review
  7. Article
  8. Strategies for Covalent Labeling of Long RNAs.Chembiochem : a European journal of chemical biology · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Seergazhi G SrivatsanDepartment of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093-0358, USA.
Yitzhak Tor
University of California, San Diego · US

Funding

Fluorescent Nucleosides and OligonucleotidesR01GM069773 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TOR, YITZHAK · 2004 to 2020
$5.0M
NOVEL APPROACHES TO THE DISCOVERY OF ANTI-HIV AGENTSR01AI047673 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TOR, YITZHAK · 2000 to 2007
$2.3M
NIAID NIH HHS AI 47673NIAID NIH HHS R01 AI047673NIGMS NIH HHS GM 069773NIGMS NIH HHS R01 GM069773
6 · The paper itself

Abstract

Fluorescent nucleobase analogues that respond to changes in their microenvironment are valuable for studying RNA structure, dynamics, and recognition. The most commonly used fluorescent ribonucleoside is 2-aminopurine, a highly responsive purine analogue. Responsive isosteric fluorescent pyrimidine analogues are, however, rare. Appending five-membered aromatic heterocycles at the 5-position on a pyrimidine core has recently been found to provide a family of responsive fluorescent nucleoside analogues with emission in the visible range. To explore the potential utility of this chromophore for studying RNA-ligand interactions, an efficient incorporation method is necessary. Here we describe the synthesis of the furan-containing ribonucleoside and its triphosphate, as well as their basic photophysical characteristics. We demonstrate that T7 RNA polymerase accepts this fluorescent ribonucleoside triphosphate as a substrate in in vitro transcription reactions and very efficiently incorporates it into RNA oligonucleotides, generating fluorescent constructs. Furthermore, we utilize this triphosphate for the enzymatic preparation of a fluorescent bacterial A-site, an RNA construct of potential therapeutic utility. We show that the binding of this RNA target to aminoglycoside antibiotics, its cognate ligands, can be effectively monitored by fluorescence spectroscopy. These observations are significant since isosteric emissive U derivatives are scarce and the trivial synthesis and effective enzymatic incorporation of the furan-containing U triphosphate make it accessible to the biophysical community.

Indexed as

AminoglycosidesBinding SitesFluorescent DyesFuransNucleic Acid ConformationPyrimidine NucleotidesRibonucleotidesRNARNA, MessengerSpectrometry, FluorescenceSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationAminoglycosidesFluorescent DyesFuransPyrimidine NucleotidesRibonucleotidesRNARNA, Messenger

Identifiers

PMID17256858
PMCPMC2517582
OpenAlexW2029443955

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.